US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 2.330
  • +0.140+6.39%
Close Feb 14 16:00 ET
  • 2.360
  • +0.030+1.29%
Post 20:01 ET
19.23MMarket Cap-1.61P/E (TTM)

About CervoMed Company

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.

Company Profile

SymbolCRVO
Company NameCervoMed
Listing DateNov 9, 2016
Founded1995
CEODr. John J. Alam, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address20 Park Plaza,Suite 424
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02216
Phone1-617-744-4400
Websitehttp://www.cervomed.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John J. Alam, M.D.
  • Chief Executive Officer, President and Director
  • 815.16K
  • Dr. Robert Joseph Cobuzzi, Jr,PhD
  • Chief Operating Officer and Director
  • 703.12K
  • William R. Elder
  • General Counsel, Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
  • 468.35K
  • Kelly Blackburn
  • Senior Vice President, Clinical Development
  • 465.74K
  • Dr. Joshua S. Boger,PhD
  • Chairman of the Board
  • --
  • Dr. Sylvie Gregoire,Pharm.D.
  • Director
  • 376.94K
  • Jane H. Hollingsworth
  • Independent Director
  • 82.91K
  • Jeffrey V. Poulton
  • Independent Director
  • 47.20K
  • Frank Zavrl
  • Independent Director
  • 47.76K
  • Dr. Marwan Noel Sabbagh, M.D.
  • Independent Director
  • 41.15K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!